217 related articles for article (PubMed ID: 20209503)
21. Interaction between conventional dendritic cells and natural killer cells is integral to the activation of effective antiviral immunity.
Andoniou CE; van Dommelen SL; Voigt V; Andrews DM; Brizard G; Asselin-Paturel C; Delale T; Stacey KJ; Trinchieri G; Degli-Esposti MA
Nat Immunol; 2005 Oct; 6(10):1011-9. PubMed ID: 16142239
[TBL] [Abstract][Full Text] [Related]
22. The role of LY49 NK cell subsets in the regulation of murine cytomegalovirus infections.
Tay CH; Yu LY; Kumar V; Mason L; Ortaldo JR; Welsh RM
J Immunol; 1999 Jan; 162(2):718-26. PubMed ID: 9916691
[TBL] [Abstract][Full Text] [Related]
23. Bovine natural killer cells.
Boysen P; Storset AK
Vet Immunol Immunopathol; 2009 Aug; 130(3-4):163-77. PubMed ID: 19339058
[TBL] [Abstract][Full Text] [Related]
24. The expression of human natural killer cell receptors in early life.
Sundström Y; Nilsson C; Lilja G; Kärre K; Troye-Blomberg M; Berg L
Scand J Immunol; 2007; 66(2-3):335-44. PubMed ID: 17635811
[TBL] [Abstract][Full Text] [Related]
25. NK cells and NKT cells in innate defense against viral infections.
Biron CA; Brossay L
Curr Opin Immunol; 2001 Aug; 13(4):458-64. PubMed ID: 11498302
[TBL] [Abstract][Full Text] [Related]
26. NK cell recognition and killing of melanoma cells is controlled by multiple activating receptor-ligand interactions.
Morgado S; Sanchez-Correa B; Casado JG; Duran E; Gayoso I; Labella F; Solana R; Tarazona R
J Innate Immun; 2011; 3(4):365-73. PubMed ID: 21576932
[TBL] [Abstract][Full Text] [Related]
27. NK cells prevalence, subsets and function in viral hepatitis C.
Zeromski J; Mozer-Lisewska I; Kaczmarek M; Kowala-Piaskowska A; Sikora J
Arch Immunol Ther Exp (Warsz); 2011 Dec; 59(6):449-55. PubMed ID: 21972016
[TBL] [Abstract][Full Text] [Related]
28. Expansion and activation of NK cell populations in a gammaherpesvirus infection.
Thomson RC; Petrik J; Nash AA; Dutia BM
Scand J Immunol; 2008 May; 67(5):489-95. PubMed ID: 18363592
[TBL] [Abstract][Full Text] [Related]
29. Imbalance of NKG2D and its inhibitory counterparts: how does tumor escape from innate immunity?
Zhang C; Zhang J; Wei H; Tian Z
Int Immunopharmacol; 2005 Jul; 5(7-8):1099-111. PubMed ID: 15914316
[TBL] [Abstract][Full Text] [Related]
30. Natural killer cells regulate diverse T cell responses.
Crome SQ; Lang PA; Lang KS; Ohashi PS
Trends Immunol; 2013 Jul; 34(7):342-9. PubMed ID: 23601842
[TBL] [Abstract][Full Text] [Related]
31. Modulation of natural killer (NK) receptors on NK (CD3-/CD56+), T (CD3+/CD56-) and NKT-like (CD3+/CD56+) cells after heart transplantation.
Aguilar P; Mathieu CP; Clerc G; Ethevenot G; Fajraoui M; Mattei S; Faure GC; Bene MC
J Heart Lung Transplant; 2006 Feb; 25(2):200-5. PubMed ID: 16446221
[TBL] [Abstract][Full Text] [Related]
32. Roles of natural killer cells in antiviral immunity.
Waggoner SN; Reighard SD; Gyurova IE; Cranert SA; Mahl SE; Karmele EP; McNally JP; Moran MT; Brooks TR; Yaqoob F; Rydyznski CE
Curr Opin Virol; 2016 Feb; 16():15-23. PubMed ID: 26590692
[TBL] [Abstract][Full Text] [Related]
33. CD4+CD25+ regulatory T cells inhibit natural killer cell functions in a transforming growth factor-beta-dependent manner.
Ghiringhelli F; Ménard C; Terme M; Flament C; Taieb J; Chaput N; Puig PE; Novault S; Escudier B; Vivier E; Lecesne A; Robert C; Blay JY; Bernard J; Caillat-Zucman S; Freitas A; Tursz T; Wagner-Ballon O; Capron C; Vainchencker W; Martin F; Zitvogel L
J Exp Med; 2005 Oct; 202(8):1075-85. PubMed ID: 16230475
[TBL] [Abstract][Full Text] [Related]
34. Noncytolytic control of viral infections by the innate and adaptive immune response.
Guidotti LG; Chisari FV
Annu Rev Immunol; 2001; 19():65-91. PubMed ID: 11244031
[TBL] [Abstract][Full Text] [Related]
35. Antiviral NK cell responses in HIV infection: I. NK cell receptor genes as determinants of HIV resistance and progression to AIDS.
Iannello A; Debbeche O; Samarani S; Ahmad A
J Leukoc Biol; 2008 Jul; 84(1):1-26. PubMed ID: 18388298
[TBL] [Abstract][Full Text] [Related]
36. The human decidual NK-cell response to virus infection: what can we learn from circulating NK lymphocytes?
Le Bouteiller P; Siewiera J; Casart Y; Aguerre-Girr M; El Costa H; Berrebi A; Tabiasco J; Jabrane-Ferrat N
J Reprod Immunol; 2011 Mar; 88(2):170-5. PubMed ID: 21277025
[TBL] [Abstract][Full Text] [Related]
37. NKG2D-mediated natural killer cell protection against cytomegalovirus is impaired by viral gp40 modulation of retinoic acid early inducible 1 gene molecules.
Lodoen M; Ogasawara K; Hamerman JA; Arase H; Houchins JP; Mocarski ES; Lanier LL
J Exp Med; 2003 May; 197(10):1245-53. PubMed ID: 12756263
[TBL] [Abstract][Full Text] [Related]
38. NK cell receptor and ligand composition influences the clearance of SARS-CoV-2.
Hsieh WC; Lai EY; Liu YT; Wang YF; Tzeng YS; Cui L; Lai YJ; Huang HC; Huang JH; Ni HC; Tsai DY; Liang JJ; Liao CC; Lu YT; Jiang L; Liu MT; Wang JT; Chang SY; Chen CY; Tsai HC; Chang YM; Wernig G; Li CW; Lin KI; Lin YL; Tsai HK; Huang YT; Chen SY
J Clin Invest; 2021 Nov; 131(21):. PubMed ID: 34720095
[TBL] [Abstract][Full Text] [Related]
39. NK cells recognize and lyse Ewing sarcoma cells through NKG2D and DNAM-1 receptor dependent pathways.
Verhoeven DH; de Hooge AS; Mooiman EC; Santos SJ; ten Dam MM; Gelderblom H; Melief CJ; Hogendoorn PC; Egeler RM; van Tol MJ; Schilham MW; Lankester AC
Mol Immunol; 2008 Sep; 45(15):3917-25. PubMed ID: 18657862
[TBL] [Abstract][Full Text] [Related]
40. MCMV glycoprotein gp40 confers virus resistance to CD8+ T cells and NK cells in vivo.
Krmpotić A; Busch DH; Bubić I; Gebhardt F; Hengel H; Hasan M; Scalzo AA; Koszinowski UH; Jonjić S
Nat Immunol; 2002 Jun; 3(6):529-35. PubMed ID: 12021778
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
